Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epidemiology of Parkinson’s disease
Ole‐Bjørn Tysnes, Anette Storstein
Journal of Neural Transmission (2017) Vol. 124, Iss. 8, pp. 901-905
Closed Access | Times Cited: 2044

Showing 1-25 of 2044 citing articles:

The gut microbiota–brain axis in behaviour and brain disorders
Lívia H. Morais, Henry L. Schreiber, Sarkis K. Mazmanian
Nature Reviews Microbiology (2020) Vol. 19, Iss. 4, pp. 241-255
Closed Access | Times Cited: 1451
Inflammation in CNS neurodegenerative diseases
Jodie Stephenson, Erik Nutma, Paul van der Valk, et al.
Immunology (2018) Vol. 154, Iss. 2, pp. 204-219
Open Access | Times Cited: 808
The role of JAK/STAT signaling pathway and its inhibitors in diseases
Ping Xin, Xiaoyun Xu, Chengjie Deng, et al.
International Immunopharmacology (2020) Vol. 80, pp. 106210-106210
Closed Access | Times Cited: 712
Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease
Benjamin G. Trist, Dominic J. Hare, Kay L. Double
Aging Cell (2019) Vol. 18, Iss. 6
Open Access | Times Cited: 575
The Gut-Brain Axis: How Microbiota and Host Inflammasome Influence Brain Physiology and Pathology
Andrina Rutsch, Johan B. Kantsjö, Francesca Ronchi
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 567
Anti-Inflammatory and Immunomodulatory Effects of Probiotics in Gut Inflammation: A Door to the Body
Fernanda Cristofori, Vanessa Nadia Dargenio, Costantino Dargenio, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 550
Fecal microbiota transplantation protects rotenone-induced Parkinson’s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis
Zhe Zhao, Jingwen Ning, Xiu‐Qi Bao, et al.
Microbiome (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 372
Ferroptosis Mechanisms Involved in Neurodegenerative Diseases
Cadiele Oliana Reichert, Fábio Alessandro de Freitas, Juliana Sampaio‐Silva, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8765-8765
Open Access | Times Cited: 321
Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson’s Disease
Valentina Caputi, Maria Cecilia Giron
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 6, pp. 1689-1689
Open Access | Times Cited: 303
Sleep Health: An Opportunity for Public Health to Address Health Equity
Lauren Hale, Wendy Troxel, Daniel J. Buysse
Annual Review of Public Health (2020) Vol. 41, Iss. 1, pp. 81-99
Open Access | Times Cited: 297
Oxidative stress and regulated cell death in Parkinson’s disease
Pedro A. Dionísio, Joana D. Amaral, Cecília M. P. Rodrigues
Ageing Research Reviews (2021) Vol. 67, pp. 101263-101263
Closed Access | Times Cited: 286
Impaired dopamine metabolism in Parkinson’s disease pathogenesis
Anna Masato, Nicoletta Plotegher, Daniela Boassa, et al.
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 269
Machine Learning for the Diagnosis of Parkinson's Disease: A Review of Literature
Jie Mei, Christian Desrosiers, Johannes Frasnelli
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 268
Astrocyte contribution to dysfunction, risk and progression in neurodegenerative disorders
Ashley N. Brandebura, Adrien Paumier, Tarik Seref Onur, et al.
Nature reviews. Neuroscience (2022) Vol. 24, Iss. 1, pp. 23-39
Open Access | Times Cited: 257
Mitochondrial dysfunction in neurological disorders: Exploring mitochondrial transplantation
Pedro Norat, Sauson Soldozy, Jennifer D. Sokolowski, et al.
npj Regenerative Medicine (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 242
Trial of Cinpanemab in Early Parkinson’s Disease
Anthony E. Lang, Andrew Siderowf, Eric A. Macklin, et al.
New England Journal of Medicine (2022) Vol. 387, Iss. 5, pp. 408-420
Open Access | Times Cited: 233
Parkinson’s disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1/Th2/T17 and Treg in drug-naïve and drug-treated patients
Nataša Kuštrimović, Cristoforo Comi, Luca Magistrelli, et al.
Journal of Neuroinflammation (2018) Vol. 15, Iss. 1
Open Access | Times Cited: 226
Resveratrol: from enhanced biosynthesis and bioavailability to multitargeting chronic diseases
Naveet Pannu, Archana Bhatnagar
Biomedicine & Pharmacotherapy (2018) Vol. 109, pp. 2237-2251
Open Access | Times Cited: 213
Circulating microRNAs as potential biomarkers for psychiatric and neurodegenerative disorders
Merel M.J. van den Berg, Julian Krauskopf, Johannes G. Ramaekers, et al.
Progress in Neurobiology (2019) Vol. 185, pp. 101732-101732
Open Access | Times Cited: 208
The Role of Lipids in Parkinson’s Disease
Helena Xicoy, Bé Wieringa, Gerard J.M. Martens
Cells (2019) Vol. 8, Iss. 1, pp. 27-27
Open Access | Times Cited: 201
On the Neuroprotective Role of Astaxanthin: New Perspectives?
Christian Galasso, Ida Orefice, Paola Pellone, et al.
Marine Drugs (2018) Vol. 16, Iss. 8, pp. 247-247
Open Access | Times Cited: 195
Applications of Phyto-Nanotechnology for the Treatment of Neurodegenerative Disorders
Tanima Bhattacharya, Giselle A. Borges e Soares, Hitesh Chopra, et al.
Materials (2022) Vol. 15, Iss. 3, pp. 804-804
Open Access | Times Cited: 188
Interplay of gut microbiota and oxidative stress: Perspective on neurodegeneration and neuroprotection
Shruti Shandilya, Sandeep Kumar, Niraj Kumar Jha, et al.
Journal of Advanced Research (2021) Vol. 38, pp. 223-244
Open Access | Times Cited: 182
Dysbiosis of gut microbiota in a selected population of Parkinson's patients
Daniele Pietrucci, Rocco Cerroni, Valeria Unida, et al.
Parkinsonism & Related Disorders (2019) Vol. 65, pp. 124-130
Closed Access | Times Cited: 178
Flavonoids as Therapeutic Agents in Alzheimer’s and Parkinson’s Diseases: A Systematic Review of Preclinical Evidences
Roxana Braga de Andrade Teles, Tâmara Coimbra Diniz, Tiago Coimbra Costa Pinto, et al.
Oxidative Medicine and Cellular Longevity (2018) Vol. 2018, Iss. 1
Open Access | Times Cited: 176
Page 1 - Next Page

Scroll to top